Next Article in Journal
Multidrug Efflux Systems in Helicobacter cinaedi
Previous Article in Journal
Gelation Behavior of 5-Chloro-8-hydroxyquinoline, an Antituberculosis Agent in Aqueous Alcohol Solutions
Article Menu

Export Article

Open AccessShort Note
Antibiotics 2012, 1(1), 25-28;

Investigations into the Antibacterial Activity of the Silver-Based Antibiotic Drug Candidate SBC3

Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland
Author to whom correspondence should be addressed.
Received: 29 October 2012 / Revised: 15 November 2012 / Accepted: 15 November 2012 / Published: 20 November 2012
Full-Text   |   PDF [268 KB, uploaded 20 November 2012]


The synthesis of N-heterocyclic carbene (NHC) silver(I) acetate complexes with varying lipophilic benzyl-substituents at the 1 and 3 positions starting from 4,5-diphenylimidazole, opened a new class of antibiotic drug candidates. These NHC-silver(I) acetate derivatives exhibit interesting structural motifs in the solid state and proved to be soluble and stable in biological media. The leading candidate, SBC3, which was known to exhibit good antibacterial activity in preliminary Kirby-Bauer tests, was tested quantitatively using minimum inhibitory concentrations. NHC-silver(I) acetate complexes were found to have MIC values ranging from 20 to 3.13 μg/mL for a variety of Gram-positive, Gram-negative and mycobacteria tested. These values represent good antibiotic activities against potential pathogens when compared to clinically approved antibiotics. Most striking is the fact that SBC3 is active against methicillin-resistant Staphylococcus aureus with a MIC value of 12.5 μg/mL. View Full-Text
Keywords: silver; N-heterocyclic carbene; MRSA silver; N-heterocyclic carbene; MRSA
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Sharkey, M.A.; O'Gara, J.P.; Gordon, S.V.; Hackenberg, F.; Healy, C.; Paradisi, F.; Patil, S.; Schaible, B.; Tacke, M. Investigations into the Antibacterial Activity of the Silver-Based Antibiotic Drug Candidate SBC3. Antibiotics 2012, 1, 25-28.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top